Here's a look at some of the most interesting and thematic responses you-our readers-provided for Pharmaceutical Technology's anniversary survey of industry advances and directions.
Here's a look at some of the most interesting and thematic responses you—our readers—provided for Pharmaceutical Technology's anniversary survey of industry advances and directions.
Which events significantly affected or caused changes in pharmaceutical manufacturing?
"My graduation from college."
"Better chemistry," "gene technology," and "train(ing) dogs to sniff counterfeit drugs" will impact the future direction of pharmaceutical manufacturing.
The rationalization of small-molecule manufacturing facilities in APIs.
"Is the leading edge of pharma."
On the use of information technology:
"There is no replacement for an advanced and validated computerized system."
When it comes to formulation development and manufacturing practices.
"The advice from our management is to have 50% of our workload outsourced—and especially routine work."
Thanks to advanced analytical technologies in NIR.
"(we) don't actually need to prepare the sample tediously."
With regard to the GMPs for the 21st century.
"It's been a long time since 1978, and it is time to update."
"...Most companies have found a way around..."
21 CFR Part 11 regulation.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.